Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Apollo Global Management heads into its November 3 earnings with a stock that has fallen 13% over the past month to $115.95, yet carries an analyst consensus pointing to targets well above current levels.
The most striking feature of this week's setup is the gap between price and Street opinion. The mean analyst price target is $151.45, implying around 31% upside from Tuesday's close. Wells Fargo opened coverage on October 2 with an Equal-Weight rating and a $127 target, a cautious entry point that still sits above the stock. JP Morgan maintained Overweight in early September and lifted its target to $154. UBS and Barclays both raised targets to $172 and $157 respectively after the August earnings print. The direction of travel from the larger houses is clearly bullish. The analyst recommendation differential factor ranks in the 91st percentile, and the forward EPS growth score ranks in the 86th. That is a picture of a stock the Street thinks is too cheap, not one facing fundamental deterioration. The bear case centres on the downward revision to 2025 spread-related earnings growth and competitive pressure in the retail channel, but even the cautious initiations are coming in with targets above $127.
The lending market tells a low-conviction short story. Short interest has drifted from roughly 20.3 million shares in early September to 23.2 million now, a 12% rise over the month, but at just under 4% of the free float that is not a crowded short. Availability is extraordinarily loose at 1,214%, meaning for every share currently borrowed there are more than twelve available for new shorts to access. Borrowing costs ticked up 51% on the week to 0.43%, which sounds dramatic but remains firmly in the "cheap" range at less than half a percent annualised. The ORTEX short score of 46.8 reflects that moderate positioning and has been drifting slightly lower over the past two weeks, down from around 47.7 in late September. Options are similarly neutral. The put/call ratio is 0.95, barely above its 20-day mean of 0.94 and less than a third of a standard deviation above it. The 52-week PCR high is 1.00. Nothing in the options market is flashing unusual defensiveness.
Ownership has one feature worth flagging. The company carries multiple Schedule 13D filers on its register, a classification that denotes activist intent in SEC filings. The founders are among them: Leon Black filed a 13D/A last disclosed at 6.8% of shares outstanding, Joshua Harris at 5.9%, and Marc Rowan at around 6.0%. LDB 2025 LLC, an entity associated with the Leon Black family office structure, filed a fresh Schedule 13D in August 2026, disclosing 3 million shares at 0.51% of class. The July 2026 insider activity shows a "J" transaction code for LDB 2014 LLC covering 3 million shares, which reflects a transfer rather than an open-market sale. The only conventional open-market sale in the past 90 days is CFO Kelly Martin's disposal of 3,000 shares at $140.85 in mid-August, worth around $423,000. On net, insider open-market activity is negligible in terms of signal. As a standing caveat, 13D/G positions are event-driven disclosures around the 5% threshold, and holders who drop below that level may not file again.
The last two earnings events offer a useful backdrop. After the July 31 report, the stock gained 7.6% on the day and added another 6% over the following week. After the August 4 report the day move was flat at 0.25%, but the five-day follow-through was 8.4%. Apollo has rewarded holders after recent prints, and the company's own data shows Wikipedia page views running at an elevated attention level, with a retail attention z-score of 1.81 as of late September, suggesting the name is getting more public interest than usual. That is a colour reading rather than a leading indicator for revenues, but it sits alongside the broader theme of growing retail interest in private markets vehicles.
Valuation multiples have compressed with the stock. The price-to-book ratio has fallen 0.46 points over the past 30 days to 2.61. The PE has dropped almost 1.9 turns to 11.3x. With November 3 earnings now 27 days away, the central question is whether the monthly compression in multiples has created a more attractive entry point, or whether the market is right to run the stock below its consensus targets ahead of what is shaping up as a crowded print.
See the live data behind this article on ORTEX.
Open APO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
